Predictors of radiotherapy outcome in patients with T2 supraglottic carcinoma.

Eur Arch Otorhinolaryngol

Department of Radiation Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-100, Gliwice, Poland.

Published: March 2012

The decision regarding treatment of early supraglottic carcinoma remains controversial. Single institution clinical data of patients with T2 supraglottic carcinoma treated exclusively with radiotherapy in terms of prognostic factors and treatment results were analyzed. Patient-related factors that would potentially by useful for optimal therapeutic decision to be undertaken were especially investigated. Between 1994 and 2004, 78 patients with T2 supraglottic carcinoma underwent radiotherapy (RT) in Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Poland. There were 54 (69%) males and 24 (31%) females in the median age of 61 years. There were 17 (22%) patients with N+. Median body mass of patients before (BM0) and after RT (BM1) was 74 kg (range 45.2-130 kg) and 72.9 kg (range 49.9-122.5 kg), respectively. Median hemoglobin concentrations before (Hb0) and after (Hb1) RT were 14.3 and 13.4 g/dl, respectively. Median change of Hb concentration during RT (dHb) was -0.8 g/dl. All were treated up to total doses (TD) ranged from 62.5 to 72 Gy. The overall treatment time (OTT) ranged from 30 to 70 days. Estimates of local control (LC), ultimate local control (uLC), and overall survival (OS) were calculated using the Kaplan-Meier method. Log rank statistics, Cox proportional hazard model and step-wise Cox regression hazard model were employed to identify prognostic factors for LC, uLC, and OS in univariate and multivariate analyses. The 5-year LC, RC, uLC and OS rates were 85, 92, 88, and 56%, respectively. In multivariate analysis N+ (p = 0.01) and prolonged OTT (p = 0.03) significantly decreased LC. Females (p = 0.02), higher BM0 (p = 0.03), and HB0 (p = 0.006) significantly prolonged OS. Patient-related factors like gender, hemoglobin concentration, and body mass may predict treatment outcome. Radiotherapy is effective for T2 supraglottic carcinoma of the larynx unless higher dose intensity is provided. Involved regional lymph nodes significantly deteriorate locoregional cure.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-011-1847-9DOI Listing

Publication Analysis

Top Keywords

supraglottic carcinoma
20
patients supraglottic
12
prognostic factors
8
patient-related factors
8
body mass
8
local control
8
hazard model
8
patients
5
supraglottic
5
carcinoma
5

Similar Publications

Squamous cell carcinoma in the posterior larynx: A rare localization of supraglottic T1 laryngeal cancer. Case report.

Oral Oncol

February 2025

Department of Otolaryngology and Laryngological Oncology, Poznan University of Medical Sciences, 49 Przybyszewskiego Street, 60-355 Poznań, Poland. Electronic address:

Laryngeal squamous cell carcinoma (SCC) is a common malignancy of the head and neck, typically presenting in older patients with a history of smoking or alcohol use. However, its progression can be unpredictable, with cases of long-term dormancy followed by rapid progression. We report a case of a 71-year-old male with an 18-year history of otolaryngological treatment who presented with a newly diagnosed laryngeal SCC after multiple benign findings in previous laryngoscopies.

View Article and Find Full Text PDF

To investigate the influence of early dysphagia on quality of life in patients with partial laryngectomy, and to investigate the application value of Flexible Endoscopic Evaluation of Swallowing (FEES). This study included 30 inpatients who underwent partial laryngectomy due to laryngeal cancer. In the early postoperative period, a comprehensive assessment was conducted on each patient, encompassing Videofluoroscopic Swallowing Study (VFSS), Flexible Endoscopic Evaluation of Swallowing (FEES), and MD Anderson Dysphagia Inventory (MDADI).

View Article and Find Full Text PDF

[Reconstruction of phonatory function using a tubular free flap from upper-lateral upper arm after near-total laryngectomy].

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi

February 2025

Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P. R. China.

Objective: To explore the feasibility of reconstruction of phonatory function by using a tubular free flap from upper-lateral upper arm to repair the laryngotracheal circumferential defect after near-total laryngectomy for laryngeal cancer.

Methods: A retrospective study was conducted on 7 patients who underwent near-total laryngectomy between June 2021 and October 2023, aged from 48 to 70 years (median, 59 years), 6 males and 1 female. The disease duration ranged from 1 to 11 months, with a median of 6 months.

View Article and Find Full Text PDF

Extensive supraglottic mass-An anesthetist's nightmare.

Saudi J Anaesth

January 2025

Department of Anaesthesiology, Critical Care and Pain Medicine, All India Institute of Medical Sciences, New Delhi, India.

Supraglottic carcinoma presents significant challenges in airway management during general anesthesia. We report a case of a 26-year-old female with extensive supraglottic growth undergoing a biopsy. Awake fiber-optic intubation was performed due to the risk of airway obstruction and difficulty with direct laryngoscopy.

View Article and Find Full Text PDF

Laryngeal squamous cell carcinoma (LSCC) is characterized by diverse profiles of tumor-infiltrating lymphocytes (TILs). We aimed to investigate the potential prognostic role of TILs and programmed death-ligand 1 (PD-L1) in patients with supraglottic LSCC. The expression of PD-L1 and TILs was assessed using immunohistochemistry in 39 patients with primary supraglottic LSCC and correlated with clinicopathological characteristics and disease-free survival (DFS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!